Literature DB >> 26828971

Comparison of treatment planning parameters for dose painting head and neck plans delivered with tomotherapy.

Malgorzata Skórska1, Tomasz Piotrowski1,2, Adam Ryczkowski1, Joanna Kaźmierska2,3.   

Abstract

OBJECTIVE: The aim of this study was to determine which physical delivery parameter changes are most suitable for multiple-level dose-painting treatment plans with helical tomotherapy (HT).
METHODS: A total of 96 treatment plans were generated for 12 patients who had undergone fluorine-18 fludeoxyglucose positron emission tomography/CT ((18)F-FDG-PET/CT) scan to plan head and neck cancer treatment. Based on these PET-CT images, the dose was escalated to 96 Gy in 32 fractions as a function of PET intensity values. The intensity-based prescription was converted into seven discrete dose levels. For the same patient, different HT plans were optimized by varying parameters such as field width (FW), pitch (PF) and modulation factor (MF). Dose conformity was evaluated using quality-volume histograms, quality factors (QFs), weighted index of achievement (IOAw), coldness (IOCw) and hotness (IOHw). Moreover, doses to organs at risk (OARs), target volumes and execution time were analyzed.
RESULTS: Median QFs were the best for FW = 1.05 cm (QF = 2.10) and the worst for FW = 2.5 cm (QF = 3.04). The same trend was observed for IOAw, IOCw and IOHw. Combination of FW = 1.05 cm and MF = 5 leads to the longest beam-on time (above 25 min), whereas FW = 2.5 cm and MF = 3 lead to the shortest time (below 8 min). Data analyzed based on dose-volume histogram showed that changes in FW had the strongest impact on plan quality, whereas the effect of MF and PF changes was moderate.
CONCLUSION: HT is suitable for multiple-level dose-painting treatment plans. ADVANCES IN KNOWLEDGE: Changes in FW and MF had the greatest impact on dose distribution quality and beam-on time. Changes in PF only influenced doses to the OARs.

Entities:  

Mesh:

Year:  2016        PMID: 26828971      PMCID: PMC4846218          DOI: 10.1259/bjr.20150970

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck.

Authors:  D M Brizel; G S Sibley; L R Prosnitz; R L Scher; M W Dewhirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-05-01       Impact factor: 7.038

2.  [The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)].

Authors:  N Hodapp
Journal:  Strahlenther Onkol       Date:  2012-01       Impact factor: 3.621

3.  Adaptive dose painting by numbers for head-and-neck cancer.

Authors:  Fréderic Duprez; Wilfried De Neve; Werner De Gersem; Marc Coghe; Indira Madani
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-17       Impact factor: 7.038

Review 4.  Conformity index: a review.

Authors:  Loïc Feuvret; Georges Noël; Jean-Jacques Mazeron; Pierre Bey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-02-01       Impact factor: 7.038

5.  Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.

Authors:  Indira Madani; Wim Duthoy; Cristina Derie; Werner De Gersem; Tom Boterberg; Micky Saerens; Filip Jacobs; Vincent Grégoire; Max Lonneux; Luc Vakaet; Barbara Vanderstraeten; Wouter Bauters; Katrien Bonte; Hubert Thierens; Wilfried De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

6.  Prospective study on dosimetric comparison of helical tomotherapy and 3DCRT for craniospinal irradiation - A single institution experience.

Authors:  Anna Bandurska-Luque; Tomasz Piotrowski; Agnieszka Skrobała; Adam Ryczkowski; Krystyna Adamska; Joanna Kaźmierska
Journal:  Rep Pract Oncol Radiother       Date:  2015-01-18

7.  Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

Authors:  M Hockel; K Schlenger; B Aral; M Mitze; U Schaffer; P Vaupel
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

8.  Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.

Authors:  S K Das; M M Miften; S Zhou; M Bell; M T Munley; C S Whiddon; O Craciunescu; A H Baydush; T Wong; J G Rosenman; M W Dewhirst; L B Marks
Journal:  Med Phys       Date:  2004-06       Impact factor: 4.071

9.  Evaluation of the optimal combinations of modulation factor and pitch for Helical TomoTherapy plans made with TomoEdge using Pareto optimal fronts.

Authors:  Geert De Kerf; Dirk Van Gestel; Lobke Mommaerts; Danielle Van den Weyngaert; Dirk Verellen
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

10.  A new plan quality index for dose painting radiotherapy.

Authors:  Yang-Kyun Park; Soyeon Park; Hong-Gyun Wu; Siyong Kim
Journal:  J Appl Clin Med Phys       Date:  2014-07-08       Impact factor: 2.102

View more
  9 in total

Review 1.  Personalized radiotherapy treatment planning based on functional imaging.

Authors:  Malgorzata Skórska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-15

2.  Comparison of dose distribution for head and neck cancer patients with and without dose painting escalation during radiotherapy realized with tomotherapy unit.

Authors:  Malgorzata Skorska; Tomasz Piotrowski; Adam Ryczkowski
Journal:  Br J Radiol       Date:  2017-06-23       Impact factor: 3.039

3.  Performance of the eclipse monitor unit objective tool utilizing volumetric modulated arc therapy for rectal cancer.

Authors:  Alejandro Prado; Ángel Gaitán; Mario Leonor; Marta Manzano; Eduardo Cabello; Raúl Díaz; Alejandro Ferrando; Ana Milanés; Gustavo Pozo
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-25

4.  IMRT/VMAT dose distributions generated for HD ® and Millennium ® collimators TrueBeam ® and Clinac ® accelerators.

Authors:  Krzysztof Ślosarek; Iwona Brąclik; Wojciech Leszczyński; Joanna Kopczyńska; Wojciech Osewski; Jacek Wendykier
Journal:  Rep Pract Oncol Radiother       Date:  2018-10-10

5.  Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy.

Authors:  Elisa Jiménez-Ortega; Ana Ureba; José Antonio Baeza; Ana Rita Barbeiro; Marcin Balcerzyk; Ángel Parrado-Gallego; Amadeo Wals-Zurita; Francisco Javier García-Gómez; Antonio Leal
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

6.  Evaluation of Optimal Combination of Planning Parameters (Field Width, Pitch, and Modulation Factor) in Helical Tomotherapy for Bilateral Breast Cancer.

Authors:  C A Muthuselvi; T K Bijina; A Pichandi
Journal:  J Med Phys       Date:  2021-02-02

7.  Influence of Modulation Factor on Treatment Plan Quality and Irradiation Time in Hippocampus-Sparing Whole-Brain Radiotherapy Using Tomotherapy.

Authors:  Akihiko Ishibashi; Hiromasa Kurosaki; Kosei Miura; Nobuko Utsumi; Hideyuki Sakurai
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 8.  Treatment-integrated imaging, radiomics, and personalised radiotherapy: the future is at hand.

Authors:  Julian Malicki; Tomasz Piotrowski; Ferran Guedea; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2022-09-19

9.  Interfacility variation in treatment planning parameters in tomotherapy: field width, pitch, and modulation factor.

Authors:  Hidetoshi Shimizu; Koji Sasaki; Takashi Kubota; Hiroshi Fukuma; Takahiro Aoyama; Tohru Iwata; Hiroyuki Tachibana; Takeshi Kodaira
Journal:  J Radiat Res       Date:  2018-09-01       Impact factor: 2.724

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.